Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea
2017
Objectives:Eluxadoline is a mixed μ-opioid receptor (OR) and κ-OR agonist and δ-OR antagonist, approved for the treatment of irritable bowel syndrome with diarrhea (IBS-D). This analysis evaluated the safety and tolerability of eluxadoline 75 and 100 mg twice daily (BID) in one Phase 2 (IBS-2001) an
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
49
References
49
Citations
NaN
KQI